Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
Kim Forest Enterprise Co., Ltd. specializes in advanced precision medical products. The company equips healthcare providers with essential diagnostic devices, reagents, and analytical pipelines, enabling crucial screening tests for conditions such as cancer and inherited diseases. Its comprehensive portfolio extends to supporting cancer patients through genetic testing services, personalized drug reports, and monitoring tools. Furthermore, it caters to healthy individuals by offering non-invasive, genome-wide health assessments. Kim Forest also delivers specialized bioinformatics service items, prenatal test kits, and genetically modified models. Notably, its product range also includes SARS-CoV-2 detection kits. Established in 2004, the company is headquartered in New Taipei City, Taiwan.
Company Valuation
Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers.